We are Sorry, This Page doesn't Exist

Shares of Roche Holding AG gained 3.7% in premarket trading on Thursday after the Swiss drugmaker said it plans to run a Phase 3 clinical testing Acterma, its rheumatoid arthritis drug, as a treatment for patients with COVID-19 who have bee.....»»

Shares of Aimmune Therapeutics Inc. rose more than 12% in the extended session Friday after the Brisbane, Calif., company said the FDA has approved one of its drugs, Palforzia, for patients with peanut allergies. The o.....»»

Treating breast-cancer patients with an expensive Roche drug for six months instead of 12 reduced heart-related side effects without sacrificing effectiveness, a new study found......»»

Doctors say the new migraine drug from Amgen and Novartis can change patients’ lives by lowering the number of migraine days suffered by patients each month......»»

In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their lives and livelihoods,... To view the full story, click the title link......»»

Patients who have hereditary transthyretin-mediated amyloidosis, or hATTR, will take the drug for the rest of their lives. Alnylam Phar.....»»

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Shares of Exelixis Inc. rose more than 4% in the extended session Monday after the Alameda, Calif., biotech company said the U.S. Food and Drug Administration has approved its Cabometix drug for patients with certain types of advanced liver cancer.....»»

Switzerland's Roche will donate its new hemophilia A drug Hemlibra to a World Hemophilia Federation program, it said on Wednesday, joining rivals who also back the effort to help patients in developing countries who face treatment hurdles......»»

Facing a shortage, GLP-1 weight loss drugs by Eli Lilly & Novo Nordisk struggle to meet demand. Learn about supply issues and efforts to address them, impacting availability till 2025. read more.....»»

Rep. Katie Porter, who sits on the House Oversight Committee, has become well-known for using her "whiteboard of justice" to grill CEOs. Representative Katie Porter (D-.....»»

Shares of Heron Therapeutics Inc. gained 3.0% in trading on Thursday after the company said the Food and Drug Administration had approved its non-opioid anesthetic for use in some surgical patients. The drug, Zynrelef, is expected to bec.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»

Demand for healthcare giant Roche’s COVID-19 tests helped to offset a decline in the core drugs business, the company said on Wednesday, as it reported sales for the first quarter of 2021 and confirmed its outlook for the year......»»

In San Francisco, Drug Overdoses Claimed Twice As Many Lives As COVID-19 Authored by Ivan Pentchoukov via The Epoch Times, More than twice as many people died from accidental drug overdoses in San Francisco in 2020 than.....»»

Shares of Pfizer Inc. were up 0.1% after the drug mak.....»»

The company anno.....»»

Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»

Shares of Ionis Pharmaceuticals Inc. were down 19.6% in premarket trading on Tuesday, the day after the company said Roche Holding AG decided to discontinue.....»»

Many patients continue to avoid health care settings for fear of exposing themselves to Covid-19......»»